Data day: Trial results deliver hope for prostate cancer patients
New combination treatment can significantly reduce the risk of death among prostate cancer patients
Read More
Author: John Pinching
All trades: Syncona announces sale of portfolio company to Novartis
Company focused on founding and building global leaders in life science sold to Novartis
Read More- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
